Genetic and Epigenetic Biomarker of Cutaneous Adverse Drug Reactions
Abstract
Goals. Complex: Discover epigenetic patterns responsible for ADRs through elucidation of epigenomes in relation to transcriptomes under different conditions. Simple. Identify a screenable biomarker associated with increased incidence of cutaneous ADR as to guide medication selection (personalized medicine). Trends. Genome-wide association studies (GWAS) for ADRS require smaller samples sizes than GWAS for common disease. Increasing associations with loci outside of the MHC region. Variants located in noncoding areas of the DMA. Increasing importance of understanding epigenetic influence.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 07, 2016
- Accession Number
- AD1036151
Entities
People
- Thomas Beachkofsky
Organizations
- 59th Medical Wing